Literature DB >> 2730375

A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease.

G S Zubenko1, J Moossy, A J Martinez, G R Rao, U Kopp, I Hanin.   

Abstract

In the brains of 21 patients with Alzheimer's disease (AD) and 10 nondemented controls, senile plaques (SPs), neurofibrillary tangles (NFTs), and three indexes of cholinergic function were quantified in the middle frontal (MF) and superior temporal (ST) cortex, the entorhinal cortex (HEN), and the prosubiculum (HPR) of the hippocampus. Control brains contained few SPs without preferential distribution in any of the brain regions examined, while NFTs were found almost exclusively in the HPR. In brains from patients with AD, an inverse relationship of SPs and NFTs was found in the brain regions examined; SPs were preferentially in the neocortex and NFTs preferentially in the hippocampus. The specific activities of choline acetyltransferase and acetylcholinesterase were reduced in all regions examined, while no significant change in the density of muscarinic binding sites was observed in any region. Numerous NFTs were associated with an earlier age at onset, while the presence of SPs was related to the cholinergic deficit in AD. Earlier-onset (less than 67 years) AD was also associated with a qualitative difference in the regional distribution of NFTs compared with cases with a later onset. In the latter group, most NFTs were observed in the hippocampus, a distribution pattern similar to that observed with normal aging. In AD cases with an earlier onset, NFTs were more globally distributed in the neocortex and allocortex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730375     DOI: 10.1001/archneur.1989.00520420054022

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

1.  Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.

Authors:  V Hinz; S Grewig; B H Schmidt
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

2.  Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.

Authors:  U M Mann; E Mohr; M Gearing; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

3.  Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease.

Authors:  G A Marshall; D I Kaufer; O L Lopez; G R Rao; R L Hamilton; S T DeKosky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

4.  A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.

Authors:  M O Habert; U Spampinato; J L Mas; M L Piketty; M C Bourdel; J de Recondo; P Rondot; S Askienazy
Journal:  Eur J Nucl Med       Date:  1991

5.  RELN-expressing neuron density in layer I of the superior temporal lobe is similar in human brains with autism and in age-matched controls.

Authors:  Jasmin Camacho; Ehsan Ejaz; Jeanelle Ariza; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  Neurosci Lett       Date:  2014-07-25       Impact factor: 3.046

6.  Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.

Authors:  Sonia Boncristiano; Michael E Calhoun; Peter H Kelly; Michelle Pfeifer; Luca Bondolfi; Martina Stalder; Amie L Phinney; Dorothee Abramowski; Christine Sturchler-Pierrat; Albert Enz; Bernd Sommer; Matthias Staufenbiel; Mathias Jucker
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

7.  In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease.

Authors:  Nobuyuki Okamura; Yoshihito Funaki; Manabu Tashiro; Motohisa Kato; Yoichi Ishikawa; Masahiro Maruyama; Hiroyasu Ishikawa; Kenichi Meguro; Ren Iwata; Kazuhiko Yanai
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

8.  Effects of subchronic administration of metrifonate on cholinergic neurotransmission in rats.

Authors:  V C Hinz; J Kolb; B H Schmidt
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

9.  Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's Disease.

Authors:  Éliane Proulx; Paul Fraser; JoAnne McLaurin; Evelyn K Lambe
Journal:  J Neurosci       Date:  2015-09-16       Impact factor: 6.167

10.  Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits.

Authors:  Youngnam N Jin; Ping-Chung Chen; Jennifer A Watson; Brandon J Walters; Scott E Phillips; Karen Green; Robert Schmidt; Julie A Wilson; Gail V Johnson; Erik D Roberson; Lynn E Dobrunz; Scott M Wilson
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.